Resource Library

Resource Library

Note: The materials listed on this page might be more current than vaccine administration information in previously published CDC documents, including the 13th edition of Epidemiology and Prevention of Vaccine-Preventable Diseases (the Pink Book). Always follow the most up-to-date guidelines in the Vaccine Storage and Handling Toolkit or more recently dated materials.

Web-based Training Courses

Vaccine Administration e-Learn
A self-paced vaccine administration course that provides comprehensive training using videos, job aids, and other resources.

You Call the Shots
An interactive, web-based immunization training course that includes the latest guidelines and recommendations in vaccine practice.

Video

Videos

Title: Comfort and Restraint Techniques

Short Description: This training demonstrates comfort and restraint techniques. Determine the best position for the patient based on comfort, age, activity level, administration site, and safety. Instruct the parent on how to help the infant or child stay still so you can administer the vaccine(s) safely.

Title: Assemble a Manufacturer-filled Syringe

Short Description: This training addresses how to assemble a manufacturer-filled syringe, available for a variety of vaccines. CDC recommends that providers only prepare vaccines just prior to administration. Always prepare vaccines in a designated area that is not near any area where potentially contaminated items are placed.

 Title: Single-Dose Vial

Short Description: This training addresses how to prepare vaccine from a single-dose vial. A single-dose vial contains one dose and should be administered one time to one patient. CDC recommends that providers only prepare and draw up any vaccine just prior to administration.

Title: Expiration Date

Short Description: This training addresses how to determine when a vaccine or diluent expires—a critical step in vaccine preparation. All vaccines and diluents have an expiration date that indicates the date by which the product must be used. Vaccines and diluents may be used up to and including the expiration date unless the manufacturer indicates otherwise.

Title: Multidose Vial (MDV)

Short Description: This training addresses how to prepare vaccine from a multidose vial (MDV), which contains more than one dose of vaccine. CDC recommends that providers only prepare and draw up any vaccine just prior to administration.

Title: Beyond Use Date (BUD)

Short Description: This training addresses beyond use dates (BUDs) and how to calculate them. Sometimes vaccines must be used before the expiration date—by an earlier date known as the “beyond use date” (BUD). A BUD is calculated based on the date the vial is first entered and the storage information in the vaccine’s package insert. A BUD replaces the original expiration date.

Title: Reconstitute Lyophilized Vaccine

Short Description: This training addresses how to reconstitute a lyophilized (freeze-dried) vaccine. Lyophilized vaccine comes in the form of a powder or pellet and must be mixed with a liquid diluent before the vaccine can be administered. This process is known as “reconstitution.” Diluents vary in volume and ingredients and are specifically designed to mix with their corresponding vaccines.

Title: Rotarix (RV1)

Short Description: This training addresses how to administer RV1 rotavirus vaccine, or Rotarix. RV1 is a live, attenuated vaccine that protects infants from rotavirus infections. It is administered orally as a series of 2 doses. Rotavirus is a contagious virus that can cause gastroenteritis (inflammation of the stomach and intestines), severe, watery diarrhea, vomiting, fever, and abdominal pain. An infant can receive the first dose of RV1 at 2 months of age.

Title: RotaTeq (RV5)
Short Description: This training addresses how to administer RV5 rotavirus vaccine, or RotaTeq. RV5 protects infants from rotavirus infections and is administered orally in a series of 3 doses. Rotavirus is a contagious virus that can cause gastroenteritis (inflammation of the stomach and intestines); severe, watery diarrhea; vomiting; fever; and abdominal pain. An infant can receive the first dose of RV5 at 2 months of age.

Title: Live, Attenuated Influenza Vaccine (LAIV)
Short Description: This training addresses how to administer FluMist, the live, attenuated influenza vaccine (LAIV). FluMist is the only vaccine administered by the intranasal route. Influenza (flu) is a contagious respiratory illness caused by influenza viruses. It can cause mild to severe illness and result in serious outcomes such as hospitalization or death. The annual recommendation for influenza vaccination for children and adults means that health care providers should stay up to date in their knowledge of influenza vaccination recommendations. The best way to prevent the flu is to get vaccinated each year.

Title: Subcutaneous (SC or Subcut) Injection: Administration
Short Description: This training addresses how to administer a subcutaneous (SC or subcut) injection. Injections are commonly used in health care settings to administer vaccines for disease prevention. A needle is used to inject the vaccine into the tissue layer between the skin and the muscle. Safe injection practices minimize risk of injuries, infections, and non-infectious adverse events for both patients and providers. Health care providers are always advised to observe patients for 15 minutes after vaccination.

Title: Subcutaneous (SC or Subcut) Injection: Supplies
Short Description: This training addresses how to select the equipment needed to prepare for a subcutaneous (SC or subcut) injection. Aseptic technique must be used to protect vaccines, injection equipment, and supplies from microbial contamination. Safe and sterile injection practices minimize risk of injuries, infections, and non-infectious adverse events for both patients and providers.

Title: Subcutaneous (SC or Subcut) Injection: Sites
Short Description: This training helps providers identify subcutaneous (SC or subcut) injection sites. A needle is used to inject the vaccine into the tissue layer between the skin and the muscle. The appropriate site for a subcutaneous injection for those under 12 months of age is the fatty tissue over the anterolateral thigh. The fatty tissue over the triceps area of the upper arm is preferred for those older than 12 months of age. Safe injection practices minimize risk of injuries, infections, and non-infectious adverse events for both patients and providers. Health care providers are always advised to observe patients for 15 minutes after vaccination.

Title: Intramuscular (IM) Injection: Supplies (Children Birth through 18 Years of Age)
Short Description: This training addresses how to select the equipment needed to prepare an intramuscular (IM) injection for children from birth through 18 years of age. A supply of needles of the appropriate lengths should be available. Aseptic technique must be used to protect supplies from microbial contamination. Safe injection practices minimize risk of injuries, infections, and non-infectious adverse events for both patients and providers. Health care providers are always advised to observe patients for 15 minutes after vaccination.

Title: Intramuscular (IM) Injection: Supplies (Adults 19 Years of Age and Older)
Short Description: This training addresses how to select the equipment needed to prepare an intramuscular (IM) injection for adults 19 years of age and older. A supply of needles of the appropriate lengths should be available. Aseptic technique must be used to protect supplies from microbial contamination. Safe injection practices minimize risk of injuries, infections, and non-infectious adverse events for both patients and providers. Health care providers are always advised to observe patients for 15 minutes after vaccination.

Title: Intramuscular (IM) Injection: Sites
Short Description: This training helps providers identify intramuscular (IM) injection sites. A needle is used to inject the vaccine into the muscle. The appropriate site for an intramuscular injection for those under 2 years of age is the vastus lateralis muscle. The deltoid muscle over the triceps area of the upper arm is preferred for persons 3 years of age and older. Safe injection practices minimize risk of injuries, infections, and non-infectious adverse events for both patients and providers. Health care providers are always advised to observe patients for 15 minutes after vaccination.

Title: Documentation of Vaccines After Administration
Short Description: This training addresses how to accurately document vaccinations after administration as required by the National Childhood Vaccine Injury Act (NCVIA). Vaccine doses should be documented in both a medical record and immunization information system (IIS). Proper documentation using an IIS can help consolidate vaccination records for patients, lessen the possibility that patients will receive unnecessary doses of vaccines, and provide data for calculating a practice’s vaccination coverage. Health care providers should also give patients, parents, and/or guardians a personal vaccination record that includes the names and dates of vaccines administered.

Job Aid

Job Aids

Reference

References

Web Button

The Vaccine Administration e-Learn is a free, interactive, online educational program